MIRA Pharmaceuticals, Inc. (MIRA)

USD 1.05

(-1.87%)

Net Debt Summary of MIRA Pharmaceuticals, Inc.

MIRA Pharmaceuticals, Inc.'s latest annual net debt in 2023 was -4.59 Million USD , down -3378.01% from previous year.
MIRA Pharmaceuticals, Inc.'s latest quarterly net debt in 2024 Q2 was -2.82 Million USD , up 19.95% from previous quarter.
MIRA Pharmaceuticals, Inc. reported annual net debt of 140.25 Thousand USD in 2022, up 105.57% from previous year.
MIRA Pharmaceuticals, Inc. reported annual net debt of -2.51 Million USD in 2021, down -3008.93% from previous year.
MIRA Pharmaceuticals, Inc. reported quarterly net debt of -2.82 Million USD for 2024 Q2, up 19.95% from previous quarter.
MIRA Pharmaceuticals, Inc. reported quarterly net debt of -4.59 Million USD for 2023 FY, down -3378.01% from previous quarter.

Annual Net Debt Chart of MIRA Pharmaceuticals, Inc. (2023 - 2020)

Historical Annual Net Debt of MIRA Pharmaceuticals, Inc. (2023 - 2020)

Year	Net Debt	Net Debt Growth
2023	-4.59 Million USD	-3378.01%
2022	140.25 Thousand USD	105.57%
2021	-2.51 Million USD	-3008.93%
2020	86.5 Thousand USD	0.0%

Year	Net Debt	Net Debt Growth
2024 Q1	-3.52 Million USD	23.28%
2024 Q2	-2.82 Million USD	19.95%
2023 FY	-4.59 Million USD	-3378.01%
2023 Q2	1.9 Million USD	430.33%
2023 Q1	359.2 Thousand USD	156.11%
2023 Q4	-4.59 Million USD	20.17%
2023 Q3	-5.75 Million USD	-402.34%
2022 Q4	140.25 Thousand USD	0.0%
2022 FY	140.25 Thousand USD	105.57%
2022 Q3	- USD	0.0%
2022 Q1	-1.69 Million USD	0.0%
2021 Q1	3491.00 USD	0.0%
2021 FY	-2.51 Million USD	-3008.93%
2020 FY	86.5 Thousand USD	0.0%

Peer Net Debt Comparison of MIRA Pharmaceuticals, Inc.

Name	Net Debt	Net Debt Difference
Amgen Inc.	53.66 Billion USD	100.009%
AstraZeneca PLC	22.78 Billion USD	100.02%
Biogen Inc.	6.28 Billion USD	100.073%
Gilead Sciences, Inc.	18.9 Billion USD	100.024%
Scilex Holding Company	124.54 Million USD	103.692%
Scilex Holding Company	124.54 Million USD	103.692%